BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 36059705)

  • 1. High expression of nectin-1 indicates a poor prognosis and promotes metastasis in hepatocellular carcinoma.
    Wang X; Xing Z; Chen H; Yang H; Wang Q; Xing T
    Front Oncol; 2022; 12():953529. PubMed ID: 36059705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
    Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A
    J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491
    [No Abstract]   [Full Text] [Related]  

  • 4. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
    Front Oncol; 2021; 11():713017. PubMed ID: 34595113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis.
    Liu L; Wang Q; Wu L; Zhang L; Huang Y; Yang H; Guo L; Fang Z; Wang X
    Cancer Cell Int; 2023 Jul; 23(1):138. PubMed ID: 37452331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
    Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
    Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UHRF1 Could Be a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.
    Li D; Chen B; Zeng Y; Wang H
    Int J Gen Med; 2021; 14():6769-6776. PubMed ID: 34675635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
    Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
    Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma.
    Che Y; Wang G; Xia Q
    Front Genet; 2022; 13():937310. PubMed ID: 36105112
    [No Abstract]   [Full Text] [Related]  

  • 13. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
    Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
    Front Oncol; 2021; 11():721644. PubMed ID: 34631549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma.
    Ma Y; Yan D; Tian F; Song W; Sha R; Shang X; Lv J; Maimaiti N; Kong P; Ma X
    Am J Transl Res; 2023; 15(8):5007-5034. PubMed ID: 37692934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical significance of Nectin-4 in hepatocellular carcinoma.
    Ma J; Sheng Z; Lv Y; Liu W; Yao Q; Pan T; Xu Z; Zhang C; Xu G
    Onco Targets Ther; 2016; 9():183-90. PubMed ID: 26793002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELOVLs Predict Distinct Prognosis Value and Immunotherapy Efficacy In Patients With Hepatocellular Carcinoma.
    Zhang Y; Pang S; Sun B; Zhang M; Jiao X; Lai L; Qian Y; Yang N; Yang W
    Front Oncol; 2022; 12():884066. PubMed ID: 35912257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma.
    Zhou L; Chen G; Liu T; Liu X; Yang C; Jiang J
    Front Genet; 2022; 13():965805. PubMed ID: 36159990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
    Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
    Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.